ArticleCancer immunology, immunotherapy : CII2015

Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy.

Gail D Sckisel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.